Evidence map›Paper›PMID 31068630›Full record

ArticleScientific reports2019

A Bio-inspired Hypoxia Sensor using HIF1a-Oxygen-Dependent Degradation Domain.

Pablo Iglesias, Cristina Penas, Laura Barral-Cagiao, Elena Pazos, Jose A Costoya

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. The British journal of radiology · 2022
    Review
  5. Article
  6. Article
  7. Synthetic biology of hypoxia.The New phytologist · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Pablo IglesiasMolecular Oncology Laboratory. Departamento de Fisioloxia, Facultade de Medicina and Centro de Investigación en Medicina Molecular y Enfermedades Crónicas (CiMUS). Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
Cristina PenasCentro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Química Orgánica, Universidade de Santiago de Compostela, 15782, Santiago de Compostela, Spain.
Laura Barral-CagiaoMolecular Oncology Laboratory. Departamento de Fisioloxia, Facultade de Medicina and Centro de Investigación en Medicina Molecular y Enfermedades Crónicas (CiMUS). Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
Elena PazosDepartamento de Química, Facultade de Ciencias and Centro de Investigacións Científicas Avanzadas (CICA), Universidade da Coruña, 15071, A Coruña, Spain. elena.pazos@udc.es.ORCID http://orcid.org/0000-0001-9397-2703
Jose A CostoyaMolecular Oncology Laboratory. Departamento de Fisioloxia, Facultade de Medicina and Centro de Investigación en Medicina Molecular y Enfermedades Crónicas (CiMUS). Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain. josea.costoya@usc.es.ORCID http://orcid.org/0000-0003-3691-6419
Universidade de Santiago de Compostela · ESUniversidade da Coruña · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Functional imaging has become an important tool in oncology because it not only provides information about the size and localization of the tumour, but also about the pathophysiological features of the tumoural cells. One of the characteristic features of some tumour types is that their fast growth leads to deficient intratumoral vascularization, which results in low oxygen availability. To overcome this lack of oxygen, tumoural cells activate the neoangiogenic program by upregulating the transcription factor HIF-1α. Herein we report a non-invasive in vitro detection method of hypoxia using designed fluorescent peptide probes based on the oxygen-dependent degradation domain of HIF-1α. The fluorescent probe retains the oxygen-sensing capability of HIF-1α, so that it is stabilized under hypoxia and readily degraded by the proteasome under normoxia, thus providing direct information of the cellular oxygen availability.

Indexed as

AnimalsBiosensing TechniquesBreast NeoplasmsCell HypoxiaCell Line, TumorCobaltFemaleFluorescent DyesHumansHypoxia-Inducible Factor 1, alpha SubunitLeupeptinsMiceMice, Inbred BALB CMice, NudeMimosineOxygenbenzyloxycarbonylleucyl-leucyl-leucine aldehydeCobaltcobaltous chlorideFluorescent DyesHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitLeupeptinsMimosineOxygenPeptidesProteasome Endopeptidase ComplexProteasome Inhibitors

Identifiers

PMID31068630
PMCPMC6506541
OpenAlexW2944452579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.